Callos Andrew sold CYTK

April 15, 2026 · Form 4 insider transaction

Callos Andrew sold 7,449 shares of Cytokinetics, Incorporated at $66.02 per share, a transaction worth $491.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
7,449
Price
$66.02
Total value
$491.8K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 15, 2026
Filing dateApril 15, 2026
Shares owned after58,555
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR